Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3006 |
|
| Actual shortage: | 230 (8%) | |
| Anticipated shortage: | 20 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2747 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
28 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PROPRANOLOL | 40MG | TABLET | Resolved | 2017-08-11 | 2020-02-13 | 18769 |
| APO-PROPRANOLOL | 80MG | TABLET | Actual shortage | 2017-08-11 | 2017-10-05 | 18910 |
| APO TRIAZIDE | 50MG 25MG | TABLET | Resolved | 2017-05-16 | 2017-07-20 | 10439 |
| APO TRIAZIDE | 50MG 25MG | TABLET | Resolved | 2017-11-01 | 2018-02-17 | 27770 |
| APO TRIAZIDE | 50MG 25MG | TABLET | Resolved | 2020-11-04 | 2020-12-31 | 127762 |
| APO TRIAZIDE | 50MG 25MG | TABLET | Resolved | 2021-03-05 | 2021-06-14 | 135181 |
| APO TRIAZIDE | 25MG 50MG | TABLET | Resolved | 2023-11-06 | 2023-11-10 | 209357 |
| APO TRIAZIDE | 25MG 50MG | TABLET | Resolved | 2024-03-08 | 2024-04-05 | 221702 |
| APO-ABACAVIR | 300MG | TABLET | Resolved | 2017-03-10 | 2017-04-28 | 8 |
| APO-ABACAVIR | 300MG | TABLET | Resolved | 2018-01-03 | 2018-01-18 | 34826 |
| APO-ABACAVIR | 300MG | TABLET | Resolved | 2018-11-16 | 2019-01-23 | 67019 |
| APO-ABACAVIR | 300MG | TABLET | Resolved | 2022-04-06 | 2022-08-11 | 157992 |
| APO-ABACAVIR | 300MG | TABLET | Resolved | 2023-07-13 | 2023-08-12 | 198465 |
| APO-ABACAVIR-LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2018-01-03 | 2018-01-16 | 34878 |
| APO-ABACAVIR-LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2019-01-03 | 2019-01-23 | 71098 |
| APO-ABACAVIR-LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2019-04-22 | 2019-07-29 | 82102 |
| APO-ABACAVIR-LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2019-08-21 | 2020-01-27 | 92016 |
| APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE | 300MG 300MG 150MG | TABLET | Resolved | 2017-03-10 | 2017-05-23 | 14 |
| APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE | 300MG 300MG 150MG | TABLET | Resolved | 2018-12-05 | 2022-12-13 | 68700 |
| APO-ABIRATERONE FILM COATED TABLETS | 500MG | TABLET | Resolved | 2022-03-04 | 2022-05-19 | 156030 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CAPTO TAB 6.25MG | 6.25MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60339 |
| APO-CARVEDILOL | 12.5MG | TABLET | To be discontinued | 2024-01-26 | 2024-04-01 | 217493 |
| APO-CARVEDILOL | 3.125MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217496 |